Daniel Vitt - 03 Jan 2022 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Vitt
Issuer symbol
IMUX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2022, 15:02:49 UTC
Previous filing
11 Aug 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Award $0 +215,000 $0.000000 215,000 03 Jan 2022 Common Stock 215,000 $10.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.